OBI Pharma, Inc. won Taiwan “Venture Capital Star” The Best Investment Award

The Republic of China Venture Capital Association hosted its “Venture Capital Star” event and award night on January 15, 2014, and OBI Pharma, Inc. was selected and given the “Best Investment Award” out of over two-hundred nominations. This was the association’s first time to host the event, and accepted opened nomination to all excellent venture […]

HOMEWhat’s NewNewsOBI Pharma, Inc. won Taiwan “Venture Capital Star” The Best Investment Award

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2013.Oct.08

OBI Pharma Announces NT$ 1.5 Billion Capital Infusion

2014.Jul.21

OBI Pharma Announces Completion of Patient Enrollment in Phase 2/Phase 3 Clinical Trial of OBI-822 Active Immunotherapy for Metastatic Breast Cancer